Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-12

AUTHORS

Thi Ha Chau Tran, Christine Fardeau, Céline Terrada, Ghislaine Ducos De Lahitte, Bahram Bodaghi, Phuc Lehoang

ABSTRACT

PURPOSE: To assess the short-term efficacy and safety of intravitreal bevacizumab injections (IVB) for refractory choroidal neovascularization (CNV) secondary to uveitis. METHODS: Ten patients affected by choroidal neovascularization secondary to uveitis unresponsive to immunosuppression associated or not with photodynamic therapy (PDT) were consecutively included. All patients underwent a complete ophthalmic examination including best-corrected visual acuity (BCVA), fluorescein (FA) and indocyanine green angiographies (ICG), optical coherence tomography (OCT) at baseline, and after IVB injection (1.25 mg/0.05 ml). RESULTS: CNV was subfoveal in eight cases and juxtafoveal in two cases. Mean follow-up was 7.5 months. After treatment, the logMAR BCVA improved from 0.62 +/- 0.4 (Snellen equivalent of 20/55) to 0.45 +/- 0.35 (Snellen equivalent of 20/40) at 1 month (p = 0.01), then remained stable during the follow-up. Mean central macular thickness (CMT) was reduced from 326 +/- 95 microm before treatment to 267 +/- 28 microm (p = 0.03) at last visit. Mean number of IVB was 2.5. Leakage from inflammatory CNV was stopped in three eyes and decreased in seven eyes. No systemic or ocular adverse events were recorded. CONCLUSIONS: Intravitreal bevacizumab improves BCVA and reduces central macular thickness in eyes with inflammatory CNV refractory to immunosuppression associated or not with PDT. Further study is necessary to assess the efficacy and safety in the long term. More... »

PAGES

1685

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00417-008-0906-4

DOI

http://dx.doi.org/10.1007/s00417-008-0906-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030382755

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18682970


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1113", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Ophthalmology and Optometry", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiogenesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bevacizumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Choroidal Neovascularization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetic Retinopathy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorescein Angiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macula Lutea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uveitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Endothelial Growth Factor A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Visual Acuity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vitreous Body", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vitreous Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Saint-Vincent-de-Paul", 
          "id": "https://www.grid.ac/institutes/grid.413348.9", 
          "name": [
            "Department of Ophthalmology, Groupe Hospitalier Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France", 
            "Department of Ophthalmology, H\u00f4pital Saint Vincent de Paul, Boulevard Belfort BP 387, 59020, Lille Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tran", 
        "givenName": "Thi Ha Chau", 
        "id": "sg:person.01335574501.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335574501.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Piti\u00e9-Salp\u00eatri\u00e8re Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411439.a", 
          "name": [
            "Department of Ophthalmology, Groupe Hospitalier Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fardeau", 
        "givenName": "Christine", 
        "id": "sg:person.01076035503.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076035503.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Piti\u00e9-Salp\u00eatri\u00e8re Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411439.a", 
          "name": [
            "Department of Ophthalmology, Groupe Hospitalier Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Terrada", 
        "givenName": "C\u00e9line", 
        "id": "sg:person.0610331661.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610331661.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Piti\u00e9-Salp\u00eatri\u00e8re Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411439.a", 
          "name": [
            "Department of Ophthalmology, Groupe Hospitalier Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ducos De Lahitte", 
        "givenName": "Ghislaine", 
        "id": "sg:person.014374225617.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014374225617.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Piti\u00e9-Salp\u00eatri\u00e8re Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411439.a", 
          "name": [
            "Department of Ophthalmology, Groupe Hospitalier Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bodaghi", 
        "givenName": "Bahram", 
        "id": "sg:person.0624215221.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624215221.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Piti\u00e9-Salp\u00eatri\u00e8re Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411439.a", 
          "name": [
            "Department of Ophthalmology, Groupe Hospitalier Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lehoang", 
        "givenName": "Phuc", 
        "id": "sg:person.0740443621.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740443621.40"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1001/archopht.125.10.1422", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004382793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/iae.0b013e31815e9339", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004410006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/iae.0b013e31815e9339", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004410006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/iae.0b013e31804b3e15", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006418289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/iae.0b013e31804b3e15", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006418289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.1998.62", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009926631", 
          "https://doi.org/10.1038/eye.1998.62"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.1998.62", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009926631", 
          "https://doi.org/10.1038/eye.1998.62"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2007.02.039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021136922"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bjo.2005.089458", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021200633"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(00)00244-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021695612"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2006.10.050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022127855"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.116.11.1456", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022831480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bjo.2004.063024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025363922"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.125.11.1487", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028492794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.survophthal.2005.02.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030768584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(03)00466-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031013419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(03)00466-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031013419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(86)33611-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031254773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2005.07.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032396379"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.1987.01060110045029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032419605"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9394(01)01044-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033926538"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.1993.01090010021006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035330135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bjo.2004.046623", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035697479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bjo.2006.091538", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039009217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9394(01)00925-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039526451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00006982-200504000-00023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040444244"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00006982-200504000-00023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040444244"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bjo.2006.103135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041143024"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2006.05.067", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043980438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9394(02)01456-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045303729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00006982-200210000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046298160"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00006982-200210000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046298160"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2007.06.039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046462393"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/iae.0b013e31815e9834", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048331686"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/iae.0b013e31815e9834", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048331686"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00006982-200202000-00021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060272941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00006982-200202000-00021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060272941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00006982-200202000-00021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060272941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077443280", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-12", 
    "datePublishedReg": "2008-12-01", 
    "description": "PURPOSE: To assess the short-term efficacy and safety of intravitreal bevacizumab injections (IVB) for refractory choroidal neovascularization (CNV) secondary to uveitis.\nMETHODS: Ten patients affected by choroidal neovascularization secondary to uveitis unresponsive to immunosuppression associated or not with photodynamic therapy (PDT) were consecutively included. All patients underwent a complete ophthalmic examination including best-corrected visual acuity (BCVA), fluorescein (FA) and indocyanine green angiographies (ICG), optical coherence tomography (OCT) at baseline, and after IVB injection (1.25 mg/0.05 ml).\nRESULTS: CNV was subfoveal in eight cases and juxtafoveal in two cases. Mean follow-up was 7.5 months. After treatment, the logMAR BCVA improved from 0.62 +/- 0.4 (Snellen equivalent of 20/55) to 0.45 +/- 0.35 (Snellen equivalent of 20/40) at 1 month (p = 0.01), then remained stable during the follow-up. Mean central macular thickness (CMT) was reduced from 326 +/- 95 microm before treatment to 267 +/- 28 microm (p = 0.03) at last visit. Mean number of IVB was 2.5. Leakage from inflammatory CNV was stopped in three eyes and decreased in seven eyes. No systemic or ocular adverse events were recorded.\nCONCLUSIONS: Intravitreal bevacizumab improves BCVA and reduces central macular thickness in eyes with inflammatory CNV refractory to immunosuppression associated or not with PDT. Further study is necessary to assess the efficacy and safety in the long term.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00417-008-0906-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1005670", 
        "issn": [
          "0941-2921", 
          "1435-702X"
        ], 
        "name": "Graefe's Archive for Clinical and Experimental Ophthalmology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "246"
      }
    ], 
    "name": "Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis", 
    "pagination": "1685", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "90bd06e4ed2b367c3592efff1b75bf5c60156a8a7e357a7fbd38767e4f7f5719"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18682970"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8205248"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00417-008-0906-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030382755"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00417-008-0906-4", 
      "https://app.dimensions.ai/details/publication/pub.1030382755"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:29", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13087_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00417-008-0906-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00417-008-0906-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00417-008-0906-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00417-008-0906-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00417-008-0906-4'


 

This table displays all metadata directly associated to this object as RDF triples.

294 TRIPLES      21 PREDICATES      83 URIs      45 LITERALS      33 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00417-008-0906-4 schema:about N0c06141ecec44c71b961deb6527d322a
2 N1731c06e784145579564a3e4f5ceeab0
3 N2d72bf01c4e9424ea7f271144f8c1092
4 N3946171566a146f189a3634b317fe64f
5 N4c036d1bf99246c69dcc94d622471813
6 N4f0403f62e4248cf8ccfbb4fca88e127
7 N53ad00b158dc43c3b4bc15207f747a37
8 N57e0e80d1f12465aacceca3bbbb09ba6
9 N87df23186a1143cd8d4a1b306de7306f
10 N8b97b0e4cbb540d7b34d1fbe4dc6f0d2
11 N8dd74fb8a656414bb47d2b911b78ddb1
12 N8e306df4937a40c4b03d0c49decd8af4
13 N959fd125c9104bc2884a4e9de01945f0
14 N9ba2e9c11dc24a349213108607eebac6
15 N9ec73b862e974c0abe36e37a5de032ca
16 Na67d0222353e49cca10c95b031365117
17 Nab848522b02540759e80cb933fb3866a
18 Nb6f8a926ffec4a1e905d0cc41089bb5a
19 Nc72d1f0976a94aeabe550a50aec3a36b
20 Nc7babe3267214bbead87ce79a7480069
21 Nd1bd0da7605f4feea0cdfe963e5b06eb
22 Ndb9a0c9f1afe41188260c969b221afc4
23 Ndc5bf51714214208814160b61385df6e
24 Nec360ce6f9444555bdea99b372eb3a8f
25 anzsrc-for:11
26 anzsrc-for:1113
27 schema:author N0fb0f83cf269434eb213f79b9247c87d
28 schema:citation sg:pub.10.1038/eye.1998.62
29 https://app.dimensions.ai/details/publication/pub.1077443280
30 https://doi.org/10.1001/archopht.116.11.1456
31 https://doi.org/10.1001/archopht.125.10.1422
32 https://doi.org/10.1001/archopht.125.11.1487
33 https://doi.org/10.1001/archopht.1987.01060110045029
34 https://doi.org/10.1001/archopht.1993.01090010021006
35 https://doi.org/10.1016/j.ajo.2005.07.045
36 https://doi.org/10.1016/j.ajo.2006.10.050
37 https://doi.org/10.1016/j.ajo.2007.02.039
38 https://doi.org/10.1016/j.ajo.2007.06.039
39 https://doi.org/10.1016/j.ophtha.2006.05.067
40 https://doi.org/10.1016/j.survophthal.2005.02.010
41 https://doi.org/10.1016/s0002-9394(01)00925-4
42 https://doi.org/10.1016/s0002-9394(01)01044-3
43 https://doi.org/10.1016/s0002-9394(02)01456-3
44 https://doi.org/10.1016/s0161-6420(00)00244-x
45 https://doi.org/10.1016/s0161-6420(03)00466-4
46 https://doi.org/10.1016/s0161-6420(86)33611-x
47 https://doi.org/10.1097/00006982-200202000-00021
48 https://doi.org/10.1097/00006982-200210000-00003
49 https://doi.org/10.1097/00006982-200504000-00023
50 https://doi.org/10.1097/iae.0b013e31804b3e15
51 https://doi.org/10.1097/iae.0b013e31815e9339
52 https://doi.org/10.1097/iae.0b013e31815e9834
53 https://doi.org/10.1136/bjo.2004.046623
54 https://doi.org/10.1136/bjo.2004.063024
55 https://doi.org/10.1136/bjo.2005.089458
56 https://doi.org/10.1136/bjo.2006.091538
57 https://doi.org/10.1136/bjo.2006.103135
58 schema:datePublished 2008-12
59 schema:datePublishedReg 2008-12-01
60 schema:description PURPOSE: To assess the short-term efficacy and safety of intravitreal bevacizumab injections (IVB) for refractory choroidal neovascularization (CNV) secondary to uveitis. METHODS: Ten patients affected by choroidal neovascularization secondary to uveitis unresponsive to immunosuppression associated or not with photodynamic therapy (PDT) were consecutively included. All patients underwent a complete ophthalmic examination including best-corrected visual acuity (BCVA), fluorescein (FA) and indocyanine green angiographies (ICG), optical coherence tomography (OCT) at baseline, and after IVB injection (1.25 mg/0.05 ml). RESULTS: CNV was subfoveal in eight cases and juxtafoveal in two cases. Mean follow-up was 7.5 months. After treatment, the logMAR BCVA improved from 0.62 +/- 0.4 (Snellen equivalent of 20/55) to 0.45 +/- 0.35 (Snellen equivalent of 20/40) at 1 month (p = 0.01), then remained stable during the follow-up. Mean central macular thickness (CMT) was reduced from 326 +/- 95 microm before treatment to 267 +/- 28 microm (p = 0.03) at last visit. Mean number of IVB was 2.5. Leakage from inflammatory CNV was stopped in three eyes and decreased in seven eyes. No systemic or ocular adverse events were recorded. CONCLUSIONS: Intravitreal bevacizumab improves BCVA and reduces central macular thickness in eyes with inflammatory CNV refractory to immunosuppression associated or not with PDT. Further study is necessary to assess the efficacy and safety in the long term.
61 schema:genre research_article
62 schema:inLanguage en
63 schema:isAccessibleForFree false
64 schema:isPartOf N5efbf04c9236421199573797db9eafa4
65 Nede88c06e1ee49fea2940906b732cd4e
66 sg:journal.1005670
67 schema:name Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis
68 schema:pagination 1685
69 schema:productId N255e4cbf94434e119765b79e6693c297
70 N3ead0190dbbc4357b3cb5dc440edbafc
71 N52053e97c19c459f950dc47a34625f98
72 N5bcbc6c9eb694409a4aaf21e60a80165
73 Ne3aa9ef77c39496f9bb4a6a7c71fb917
74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030382755
75 https://doi.org/10.1007/s00417-008-0906-4
76 schema:sdDatePublished 2019-04-11T14:29
77 schema:sdLicense https://scigraph.springernature.com/explorer/license/
78 schema:sdPublisher N7a26a656c85e4e49b30b64b32f9d3247
79 schema:url http://link.springer.com/10.1007/s00417-008-0906-4
80 sgo:license sg:explorer/license/
81 sgo:sdDataset articles
82 rdf:type schema:ScholarlyArticle
83 N0092d8b7e89a4078914c61cd5ebc0f54 rdf:first sg:person.014374225617.13
84 rdf:rest Nf90b226c3f8e4a6296f0b17d4d87d0f5
85 N0c06141ecec44c71b961deb6527d322a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Male
87 rdf:type schema:DefinedTerm
88 N0fb0f83cf269434eb213f79b9247c87d rdf:first sg:person.01335574501.36
89 rdf:rest N6bced682b2af451a98914c84188a293d
90 N1731c06e784145579564a3e4f5ceeab0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Bevacizumab
92 rdf:type schema:DefinedTerm
93 N255e4cbf94434e119765b79e6693c297 schema:name dimensions_id
94 schema:value pub.1030382755
95 rdf:type schema:PropertyValue
96 N2d72bf01c4e9424ea7f271144f8c1092 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Female
98 rdf:type schema:DefinedTerm
99 N3946171566a146f189a3634b317fe64f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Adult
101 rdf:type schema:DefinedTerm
102 N3ead0190dbbc4357b3cb5dc440edbafc schema:name readcube_id
103 schema:value 90bd06e4ed2b367c3592efff1b75bf5c60156a8a7e357a7fbd38767e4f7f5719
104 rdf:type schema:PropertyValue
105 N4c036d1bf99246c69dcc94d622471813 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Macula Lutea
107 rdf:type schema:DefinedTerm
108 N4f0403f62e4248cf8ccfbb4fca88e127 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Vascular Endothelial Growth Factor A
110 rdf:type schema:DefinedTerm
111 N50779b6e9d254a33b03eed2d35321469 rdf:first sg:person.0610331661.85
112 rdf:rest N0092d8b7e89a4078914c61cd5ebc0f54
113 N52053e97c19c459f950dc47a34625f98 schema:name nlm_unique_id
114 schema:value 8205248
115 rdf:type schema:PropertyValue
116 N53ad00b158dc43c3b4bc15207f747a37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Angiogenesis Inhibitors
118 rdf:type schema:DefinedTerm
119 N57e0e80d1f12465aacceca3bbbb09ba6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Aged
121 rdf:type schema:DefinedTerm
122 N5bcbc6c9eb694409a4aaf21e60a80165 schema:name pubmed_id
123 schema:value 18682970
124 rdf:type schema:PropertyValue
125 N5efbf04c9236421199573797db9eafa4 schema:issueNumber 12
126 rdf:type schema:PublicationIssue
127 N6bced682b2af451a98914c84188a293d rdf:first sg:person.01076035503.03
128 rdf:rest N50779b6e9d254a33b03eed2d35321469
129 N7a26a656c85e4e49b30b64b32f9d3247 schema:name Springer Nature - SN SciGraph project
130 rdf:type schema:Organization
131 N87df23186a1143cd8d4a1b306de7306f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Diabetic Retinopathy
133 rdf:type schema:DefinedTerm
134 N8b97b0e4cbb540d7b34d1fbe4dc6f0d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Antibodies, Monoclonal, Humanized
136 rdf:type schema:DefinedTerm
137 N8dd74fb8a656414bb47d2b911b78ddb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Drug Administration Schedule
139 rdf:type schema:DefinedTerm
140 N8e306df4937a40c4b03d0c49decd8af4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Injections
142 rdf:type schema:DefinedTerm
143 N959fd125c9104bc2884a4e9de01945f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Vitreous Body
145 rdf:type schema:DefinedTerm
146 N9ba2e9c11dc24a349213108607eebac6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Prospective Studies
148 rdf:type schema:DefinedTerm
149 N9ec73b862e974c0abe36e37a5de032ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Fluorescein Angiography
151 rdf:type schema:DefinedTerm
152 Na67d0222353e49cca10c95b031365117 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Young Adult
154 rdf:type schema:DefinedTerm
155 Nab848522b02540759e80cb933fb3866a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Middle Aged
157 rdf:type schema:DefinedTerm
158 Nb6f8a926ffec4a1e905d0cc41089bb5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Antibodies, Monoclonal
160 rdf:type schema:DefinedTerm
161 Nc72d1f0976a94aeabe550a50aec3a36b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Treatment Outcome
163 rdf:type schema:DefinedTerm
164 Nc7babe3267214bbead87ce79a7480069 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Visual Acuity
166 rdf:type schema:DefinedTerm
167 Nd1bd0da7605f4feea0cdfe963e5b06eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Vitreous Hemorrhage
169 rdf:type schema:DefinedTerm
170 Ndb9a0c9f1afe41188260c969b221afc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Uveitis
172 rdf:type schema:DefinedTerm
173 Ndc5bf51714214208814160b61385df6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Humans
175 rdf:type schema:DefinedTerm
176 Ne3aa9ef77c39496f9bb4a6a7c71fb917 schema:name doi
177 schema:value 10.1007/s00417-008-0906-4
178 rdf:type schema:PropertyValue
179 Nec360ce6f9444555bdea99b372eb3a8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Choroidal Neovascularization
181 rdf:type schema:DefinedTerm
182 Nede88c06e1ee49fea2940906b732cd4e schema:volumeNumber 246
183 rdf:type schema:PublicationVolume
184 Nf43f062edc5548dd9885bb544afba038 rdf:first sg:person.0740443621.40
185 rdf:rest rdf:nil
186 Nf90b226c3f8e4a6296f0b17d4d87d0f5 rdf:first sg:person.0624215221.37
187 rdf:rest Nf43f062edc5548dd9885bb544afba038
188 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
189 schema:name Medical and Health Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1113 schema:inDefinedTermSet anzsrc-for:
192 schema:name Ophthalmology and Optometry
193 rdf:type schema:DefinedTerm
194 sg:journal.1005670 schema:issn 0941-2921
195 1435-702X
196 schema:name Graefe's Archive for Clinical and Experimental Ophthalmology
197 rdf:type schema:Periodical
198 sg:person.01076035503.03 schema:affiliation https://www.grid.ac/institutes/grid.411439.a
199 schema:familyName Fardeau
200 schema:givenName Christine
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076035503.03
202 rdf:type schema:Person
203 sg:person.01335574501.36 schema:affiliation https://www.grid.ac/institutes/grid.413348.9
204 schema:familyName Tran
205 schema:givenName Thi Ha Chau
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335574501.36
207 rdf:type schema:Person
208 sg:person.014374225617.13 schema:affiliation https://www.grid.ac/institutes/grid.411439.a
209 schema:familyName Ducos De Lahitte
210 schema:givenName Ghislaine
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014374225617.13
212 rdf:type schema:Person
213 sg:person.0610331661.85 schema:affiliation https://www.grid.ac/institutes/grid.411439.a
214 schema:familyName Terrada
215 schema:givenName Céline
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610331661.85
217 rdf:type schema:Person
218 sg:person.0624215221.37 schema:affiliation https://www.grid.ac/institutes/grid.411439.a
219 schema:familyName Bodaghi
220 schema:givenName Bahram
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624215221.37
222 rdf:type schema:Person
223 sg:person.0740443621.40 schema:affiliation https://www.grid.ac/institutes/grid.411439.a
224 schema:familyName Lehoang
225 schema:givenName Phuc
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740443621.40
227 rdf:type schema:Person
228 sg:pub.10.1038/eye.1998.62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009926631
229 https://doi.org/10.1038/eye.1998.62
230 rdf:type schema:CreativeWork
231 https://app.dimensions.ai/details/publication/pub.1077443280 schema:CreativeWork
232 https://doi.org/10.1001/archopht.116.11.1456 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022831480
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1001/archopht.125.10.1422 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004382793
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1001/archopht.125.11.1487 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028492794
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1001/archopht.1987.01060110045029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032419605
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1001/archopht.1993.01090010021006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035330135
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/j.ajo.2005.07.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032396379
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/j.ajo.2006.10.050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022127855
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/j.ajo.2007.02.039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021136922
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1016/j.ajo.2007.06.039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046462393
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/j.ophtha.2006.05.067 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043980438
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/j.survophthal.2005.02.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030768584
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1016/s0002-9394(01)00925-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039526451
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1016/s0002-9394(01)01044-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033926538
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1016/s0002-9394(02)01456-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045303729
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1016/s0161-6420(00)00244-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1021695612
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1016/s0161-6420(03)00466-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031013419
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1016/s0161-6420(86)33611-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031254773
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1097/00006982-200202000-00021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060272941
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1097/00006982-200210000-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046298160
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1097/00006982-200504000-00023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040444244
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1097/iae.0b013e31804b3e15 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006418289
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1097/iae.0b013e31815e9339 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004410006
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1097/iae.0b013e31815e9834 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048331686
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1136/bjo.2004.046623 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035697479
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1136/bjo.2004.063024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025363922
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1136/bjo.2005.089458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021200633
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1136/bjo.2006.091538 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039009217
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1136/bjo.2006.103135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041143024
287 rdf:type schema:CreativeWork
288 https://www.grid.ac/institutes/grid.411439.a schema:alternateName Pitié-Salpêtrière Hospital
289 schema:name Department of Ophthalmology, Groupe Hospitalier Pitié Salpêtrière, Paris, France
290 rdf:type schema:Organization
291 https://www.grid.ac/institutes/grid.413348.9 schema:alternateName Hôpital Saint-Vincent-de-Paul
292 schema:name Department of Ophthalmology, Groupe Hospitalier Pitié Salpêtrière, Paris, France
293 Department of Ophthalmology, Hôpital Saint Vincent de Paul, Boulevard Belfort BP 387, 59020, Lille Cedex, France
294 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...